NFGH
Nan Fung Group Holdings’s Entrada Therapeutics TRDA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $330K | Hold |
49,082
| – | – | 0.52% | 18 |
|
2025
Q1 | $444K | Hold |
49,082
| – | – | 0.36% | 31 |
|
2024
Q4 | $849K | Hold |
49,082
| – | – | 0.73% | 26 |
|
2024
Q3 | $784K | Hold |
49,082
| – | – | 0.68% | 25 |
|
2024
Q2 | $699K | Hold |
49,082
| – | – | 0.75% | 25 |
|
2024
Q1 | $695K | Hold |
49,082
| – | – | 0.64% | 28 |
|
2023
Q4 | $741K | Hold |
49,082
| – | – | 0.46% | 24 |
|
2023
Q3 | $775K | Hold |
49,082
| – | – | 0.63% | 21 |
|
2023
Q2 | $743K | Sell |
49,082
-24,500
| -33% | -$371K | 0.47% | 24 |
|
2023
Q1 | $1.07M | Hold |
73,582
| – | – | 0.73% | 23 |
|
2022
Q4 | $995K | Sell |
73,582
-68,011
| -48% | -$920K | 0.69% | 20 |
|
2022
Q3 | $2.23M | Sell |
141,593
-31,989
| -18% | -$504K | 1.42% | 13 |
|
2022
Q2 | $2.11M | Hold |
173,582
| – | – | 1.45% | 15 |
|
2022
Q1 | $1.63M | Buy |
+173,582
| New | +$1.63M | 0.77% | 17 |
|